Thus, understanding the complex interplay between p21, NRF2, and p53 is crucial for developing therapeutic strategies that can modulate oxidative stress responses, enhance treatment efficacy, and restore tumor-suppressive mechanisms, ultimately improving cancer treatment outcomes. This evidence concerns the gene NFE2L2 and cancer.